FREQUENCY OF HUMAN CYP2D6 MUTANT ALLELES IN A NORMAL CHINESE POPULATION

被引：26

作者：

LEE, EJD ^{[1
]}

JEYASEELAN, K ^{[1
]}

机构：

[1] NATL UNIV SINGAPORE,DEPT BIOCHEM,SINGAPORE 0511,SINGAPORE

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1994年 / 37卷 / 06期

关键词：

GENETIC POLYMORPHISM; CYP2D6; CHINESE CYTOCHROME P450;

D O I：

10.1111/j.1365-2125.1994.tb04311.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Substantial differences in the pharmacogenetics of debrisoquine hydroxylation exist between Caucasians and Chinese populations. Among Chinese, not only is the frequency of the poor metabolizer phenotype low, the contribution of the 29B mutation in the CYP2D6 gene is insignificant. By contrast the frequency of D6-J is very common (similar to 0.6) and is clearly related to the activity of debrisoquine hydroxylase. Its presence however, does not predict the poor metabolizer phenotype. The D6-C mutation was also not detectable in our population.

引用

页码：605 / 607

页数：3

共 50 条

[41] Immunohistochemical assessment of CYP2D6 expression in normal human tissue.
Zanger, UM
Fritz, P
Behrle, E
Friedel, A
Kivisto, K
Eichelbaum, M
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (04) : 456 - 456
[42] Genetic polymorphisms of CYP2D6 in Chinese mainland
Ji, L
Pan, SX
Wu, JM
Marti-Jaun, J
Hersberger, M
CHINESE MEDICAL JOURNAL, 2002, 115 (12) : 1780 - 1784
[43] Identification of CYP2D6 impaired functional alleles in Mexican Americans
Huai-Rong Luo
Andrea Gaedigk
Vasileios Aloumanis
Yu-Jui Yvonne Wan
European Journal of Clinical Pharmacology, 2005, 61 : 797 - 802
[44] The relative activity of polymorphic CYP2D6 alleles is substrate dependendent
Bogni, A
Hartung, T
Monshouwer, M
Coecke, S
DRUG METABOLISM REVIEWS, 2002, 34 : 149 - 149
[45] Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapy
Lyon, Elaine
Foster, Julie Gastier
Palomaki, Glenn E.
Pratt, Victoria M.
Reynolds, Kristen
Sabato, M. Fernanda
Scott, Stuart A.
Vitazka, Patrik
GENETICS IN MEDICINE, 2012, 14 (12) : 990 - 1000
[46] CYP2D6 Phenotyping Using Urine, Plasma, and Saliva Metabolic Ratios to Assess the Impact of CYP2D6*10 on Interindividual Variation in a Chinese Population
Chen, Rui
Zheng, Xin
Hu, Pei
FRONTIERS IN PHARMACOLOGY, 2017, 8
[47] Genetic polymorphism of CYP2D6: Malaysian Indians have the highest frequency for CYP2D6*4 in Asia
Rusli Ismail
L. Teh
European Journal of Clinical Pharmacology, 2001, 57 : 617 - 618
[48] Genetic polymorphism of CYP2D6:: Malaysian Indians have the highest frequency for CYP2D6*4 in Asia
Ismail, R
Teh, LK
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 57 (08) : 617 - 618
[49] Identification of CYP2D6 impaired functional alleles in Mexican Americans
Luo, HR
Gaedigk, A
Aloumanis, V
Wan, YJY
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (11) : 797 - 802
[50] In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles
Hertz, Daniel L.
Snavely, Anna C.
McLeod, Howard L.
Walko, Christine M.
Ibrahim, Joseph G.
Anderson, Steven
Weck, Karen E.
Magrinat, Gustav
Olajide, Oludamilola
Moore, Susan
Raab, Rachel
Carrizosa, Daniel R.
Corso, Steven
Schwartz, Garry
Peppercorn, Jeffrey M.
Evans, James P.
Jones, David R.
Desta, Zeruesenay
Flockhart, David A.
Carey, Lisa A.
Irvin, William J.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (05) : 1122 - 1130

← 1 2 3 4 5 →